Testimony at the FDA’s Public Meeting Regarding Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027
In testimony at a public meeting convened by the Food and Drug Administration (FDA), Public Citizen urged the agency to revise its draft commitment letter regarding the Medical Device User Fee Amendments for fiscal years 2023 to 2027 (MDUFA V) to strengthen its independence from regulated industry and its regulatory oversight of medical devices.
See Public Citizen’s other work regarding the medical device review process.